# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Acute myeloid leukemia

Acute Non Lymphoblastic Leukemia
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 31-40 of 634 results.
Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Patients.
Status: Recruiting
Last Changed: Sep 06, 2019
First Received: Jul 14, 2017
Disease(s): Acute Myeloid Leukaemia
Intervention(s): AZD2811, Azacitidine
Locations: Research Site, Denver, Colorado, United States
Research Site, Sarasota, Florida, United States
Research Site, Detroit, Michigan, United States
Research Site, Oklahoma City, Oklahoma, United States
Research Site, Nashville, Tennessee, United States
... and 4 other locations.
Ex-vivo Expanded γδ T Lymphocytes in Patients With Refractory/Relapsed Acute Myeloid Leukaemia
Status: Recruiting
Last Changed: Aug 07, 2019
First Received: Jul 04, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): Ex-vivo Expanded γδ T Lymphocytes
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Mar 26, 2019
First Received: Sep 10, 2014
Disease(s): Acute Myeloid Leukemia
Intervention(s): Gilteritinib, Idarubicin, Cytarabine, Daunorubicin
Locations: Site US10003, Los Angeles, California, United States
Site US10013, New Haven, Connecticut, United States
Site US10004, Chicago, Illinois, United States
Site US10009, Westwood, Kansas, United States
Site US10001, Baltimore, Maryland, United States
... and 7 other locations.
Study to Find a Safe and Effective Dose of SKI-G-801 in the Treatment of Patients With Acute Myeloid Leukemia (AML)
Status: Recruiting
Last Changed: Oct 04, 2018
First Received: Jun 20, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): SKI-G-801
Locations: Innovative Clinical Research Institute, Whittier, California, United States
Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, New York, United States
Dexamethasone Added to Intensive Chemotherapy in Older Patients With Acute Myeloid Leukemia (AML)
Status: Recruiting
Last Changed: Oct 24, 2018
First Received: Aug 01, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): Dexamethasone
Locations: CHU ANGERS - Maladies du sang, Angers, France
Ch Avignon, Avignon, France
CH de la Côte Basque - Hématologie, Bayonne, France
CHRU JEAN MINJOZ - Hématologie, Besançon, France
CHU Brest - Hôpital Morvan - Hématologie Clinique, Brest, France
... and 21 other locations.
Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML)
Status: Recruiting
Last Changed: Sep 13, 2019
First Received: Jun 25, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): Atovaquone, Cytarabine, Daunorubicin, Etoposide, Gemtuzumab Ozogamicin
Locations: Johns Hopkins Medicine, Baltimore, Maryland, United States
Baylor College of Medicine, Houston, Texas, United States
Seattle Children's Hospital, Seattle, Washington, United States
Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia (AML)
Status: Recruiting
Last Changed: Jul 24, 2019
First Received: Jun 11, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): Quizartinib, Milademetan, Milademetan
Locations: Winship Cancer Institute, Emory University, Atlanta, Georgia, United States
University of Kansas Cancer Center, Fairway, Kansas, United States
Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, United States
Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States
Duke University Cancer Center, Durham, North Carolina, United States
... and 3 other locations.
Interest of a Therapeutic Follow-up of the Cytarabine in the Acute Myeloid Leukaemia: Is There Constitutional Biomarkers
Status: Recruiting
Last Changed: Nov 09, 2017
First Received: Nov 09, 2017
Disease(s): Acute Myeloid Leukemia
Intervention(s): Blood sampling, Genetic analysis
Locations: Assistance Publique - Hopitaux de Marseille, Marseille, France
Study Impact on Outcome of Eltrombopag in Elderly Patients With Acute Myeloid Leukemia Receiving Induction Chemotherapy
Status: Recruiting
Last Changed: Oct 24, 2018
First Received: Jul 27, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): Eltrombopag, Placebo
Locations: CHU ANGERS - Maladies du sang, Angers, France
CH de la Côte Basque - Hématologie, Bayonne, France
CHU Estaing, Clermont-Ferrand, France
CHU Grenoble - Hématologie Clinique, Grenoble, France
Institut Paoli-Calmettes - Hématologie 2, Marseille, France
... and 11 other locations.
Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113
Status: Not yet recruiting
Last Changed: Sep 16, 2019
First Received: Aug 27, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): Gemtuzumab Ozogamicin, Venetoclax
Locations: Univeristy of Illinois, Chicago, Illinois, United States